AwardedPOLGoods
Dostawa produktu leczniczego zawierającego substance czynne Trastuzumabum+Pertuzumabum
- Published
- Published 15 December 2025
Overview
Trastuzumabum + Pertuzumabum, roztwór do wstrzykiwań, 600 + 1200 mg, op. 1 fiolka
objęty refundacją zgodnie z załącznikiem do Obwieszczenia MZ: B.9.FM Leczenie chorych na raka piersi 30
Trastuzumabum + Pertuzumabum, roztwór do wstrzykiwań, 600 + 600 mg, op. 1 fiolka
objęty refundacją zgodnie z załącznikiem do Obwieszczenia MZ: B.9.FM Leczenie chorych na raka piersi 510
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Published
- 15 December 2025
Pharmaceutical products
Award outcome
- Awarded value
- PLN 4,570,071
- Award date
- 13 November 2025
- Contract period
- — → 8 November 2026
- Roche Polska Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
15 December 2025
Contracting authority
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie
Procuring entityLublin, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.